Anhelli Syrenicz
Overview
Explore the profile of Anhelli Syrenicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
543
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Uzar I, Bogacz A, Sowinska-Przepiera E, Syrenicz A, Kaminski A, Wolek M, et al.
Ginekol Pol
. 2025 Jan;
96(2):109-118.
PMID: 39812362
Objectives: Hyperandrogenism is a frequently recognized endocrine imbalance in which there is excessive production of androgens. The purpose of the study was to investigate the impact of vitamin D receptor...
2.
Szczuko M, Kacprzak J, Przybylska A, Szczuko U, Poblocki J, Syrenicz A, et al.
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39519244
The potential modulation of thyroid inflammatory conditions via a gluten-free diet has been suggested after establishing a link between Hashimoto's thyroiditis (HT) and celiac disease. However, the majority of targeted...
3.
Handkiewicz-Junak D, Dedecjus M, Ambroziak U, Barczynski M, Bednarek-Papierska L, Chmielik E, et al.
Endokrynol Pol
. 2024 Sep;
75(4):339-358.
PMID: 39279304
Advances in the diagnosis and treatment of adrenocortical carcinoma (ACC), along with the development of new therapeutic and diagnostic methods, have prompted a team of experts to formulate the first...
4.
Krzyscin M, Sowinska-Przepiera E, Gruca-Stryjak K, Soszka-Przepiera E, Syrenicz I, Przepiera A, et al.
Biomedicines
. 2024 May;
12(5).
PMID: 38790996
Introduction: Metabolic syndrome (MetS), characterized by visceral obesity, glucose abnormalities, hypertension and dyslipidemia, poses a significant risk of diabetes and cardiovascular disease. Turner syndrome (TS), resulting from X chromosome abnormalities,...
5.
Sowinska-Przepiera E, Krzyscin M, Syrenicz I, Bumbuliene Z, Wajs-Syrenicz A, Przepiera A, et al.
Endokrynol Pol
. 2024 May;
75(3):279-290.
PMID: 38708911
Mental anorexia nervosa is a rare, potentially severe, chronic, and recurrent mental disorder that occurs more often in women than in men, especially during the childbearing years. The disorder is...
6.
Sowinska-Przepiera E, Krzyscin M, Syrenicz I, Cwiertnia A, Orlinska A, Cwiek D, et al.
Biomedicines
. 2024 Apr;
12(4).
PMID: 38672114
The absence of non-invasive methods for assessing bone material and structural changes is a significant diagnostic challenge. Dual-energy X-ray absorptiometry (DXA) bone mineral density (BMD) testing is the gold standard...
7.
Andrysiak-Mamos E, Sagan K, Zwarzany L, Poncyljusz W, Syrenicz A
Endokrynol Pol
. 2023 Dec;
74(6).
PMID: 38159204
Introduction: Rathke's cleft cyst (RCC) and primary empty sella syndrome (PESS) are usually incidental findings on magnetic resonance imaging (MRI) scans. In most cases, these lesions do not cause mass...
8.
Starzynski D, Rzeszotek S, Kolasa A, Grabowska M, Wiszniewska B, Kudrymska A, et al.
J Clin Med
. 2023 Aug;
12(15).
PMID: 37568488
Appendix neuroendocrine neoplasm (ANEN) treatment is based on tumor size and proliferation markers. Recently, the role of the follicle-stimulating hormone receptor (FSHR) from the clinical perspective has also been increasingly...
9.
Bednarczuk T, Kajdaniuk D, Marek B, Bolanowski M, Dedecjus M, Gilis-Januszewska A, et al.
Endokrynol Pol
. 2023 Feb;
74(1):1-4.
PMID: 36847719
Medical practice involves a high number of radiological examinations using iodinated contrast media (ICM). Therefore, it is crucial for doctors of different specialties to be aware of possible adverse effects...
10.
Ruchala M, Bossowski A, Brzozka M, Gietka-Czernel M, Hubalewska-Dydejczyk A, Kos-Kudla B, et al.
Endokrynol Pol
. 2023 Jan;
73(5):893-902.
PMID: 36621916
It is estimated that hypothyroidism treatment may be either suboptimal or excessive in about 32-45% patients treated with L-thyroxine (LT4). There are multiple possible causes of poor control of hypothyroidism,...